Clinical Trial Update: Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the usefulness of a treat-and-extend regimen using ranibizumab for neovascular age-related macular degeneration (AMD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Nagoya City University | Conditions: Neovascular Age-related Macular Degeneration | Phase 4 | Status: COMPLETED